[Clinical use of the combination prenoxidiazine-S-carboxy-methyl-cysteine].
D000328:Adult; D000368:Aged; D000996:Antitussive Agents / Q000627:therapeutic use*; D001964:Bromhexine / Q000627:therapeutic use; D001982:Bronchial Diseases / Q000188:drug therapy*; D001986:Bronchial Spasm / Q000188:drug therapy; D002233:Carbocysteine / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003371:Cough / Q000188:drug therapy; D003545:Cysteine / Q000031:analogs & derivatives*; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010069:Oxadiazoles / Q000008:administration & dosage*; D010880:Piperidines / Q000008:administration & dosage*
D000996:Antitussive Agents; D004338:Drug Combinations; D010069:Oxadiazoles; D010880:Piperidines; D002233:Carbocysteine; D003545:Cysteine; D001964:Bromhexine
Possibilità di impiego clinico dell'associazione prenoxidiazina - S -carbossimetil-cisteina.